Latest Global Markets News

IDT Australia has signed a memorandum with NASDAQ-listed Gelteq to establish a dedicated gel-based product manufacturing facility, marking a strategic expansion in pharmaceutical delivery technologies.

Future Generation Global has reported a strong 20.8% investment portfolio return for the year ending June 2025, prompting an increase in its fully franked interim dividend to 4.0 cents per share. This marks the sixth consecutive year of dividend growth for the ASX-listed investment company.

Western Yilgarn Limited announces a maiden JORC-compliant inferred mineral resource of 39.27 million tonnes at New Norcia, boosting its total bauxite portfolio to 244 million tonnes. The shallow, high-grade deposit benefits from strong infrastructure and promising metallurgical characteristics.

Syntara Limited has initiated dosing in its Phase 1c SATELLITE trial for a novel topical treatment targeting keloid scars, marking a significant step in addressing a $3.5 billion global market. The study, led by Professor Fiona Wood, will evaluate safety and early efficacy over three months.

Biome Australia Limited has reported a 69% increase in international sales revenue for FY25, reaching $1.5 million, driven by new strategic distribution agreements across Ireland, New Zealand, and Canada.

Peninsula Energy has locked in a $15 million debt facility from Davidson Kempner to advance commissioning at its Lance uranium project and support an upcoming equity raise. The funding aims to sustain momentum towards production resumption and ASX relisting.

Telix Pharmaceuticals has achieved a key milestone with its next-generation prostate cancer imaging agent, Gozellix, receiving a permanent HCPCS code from U.S. Medicare. This paves the way for broader reimbursement and market adoption starting October 2025.

Kingsland Minerals has initiated metallurgical testing to explore rutile and gallium extraction from its Leliyn Graphite Project, aiming to enhance project value amid shifting global supply chains.

BlackRock Investment Management announces an estimated 33.12 cents per unit distribution for its iShares Global High Yield Bond (AUD Hedged) ETF for the June 2025 period, predominantly sourced from foreign income. The detailed tax breakdown aims to assist investors, especially non-residents, in managing withholding tax obligations.

BlackRock Investment Management has released the estimated distribution components for the iShares Core MSCI World ex Australia ESG ETF for the period ending 30 June 2025, outlining key income sources and tax implications for investors.

Betashares Capital Ltd has released the estimated annual distribution components for its Global Sustainability Leaders ETF (ETHI) for the 2024-25 financial year, highlighting a complex mix of foreign income and capital gains.

EVE Health Group has placed its first commercial purchase order for Dyspro™, a cannabinoid-based pharmaceutical targeting painful menstruation, signaling a key step toward market entry. The product is set for manufacturing and distribution within weeks, tapping into a rapidly growing global women’s health market.